BRIEF-Coeptis Therapeutics Secures Worldwide Development & Commercialization Rights To Next-Generation Gear Cell Therapy Platform

Reuters
11 Mar
BRIEF-Coeptis <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Secures Worldwide Development & Commercialization Rights To Next-Generation Gear Cell Therapy Platform

March 11 (Reuters) - Coeptis Therapeutics Holdings Inc COEP.O:

  • COEPTIS THERAPEUTICS: SECURES WORLDWIDE DEVELOPMENT & COMMERCIALIZATION RIGHTS TO NEXT-GENERATION GEAR CELL THERAPY PLATFORM

  • COEPTIS THERAPEUTICS: FORMED NEW MAJORITY-OWNED SUBSIDIARY, GEAR THERAPEUTICS, INC.

  • COEPTIS THERAPEUTICS: GEAR LICENSE AGREEMENT WITH VYGEN-BIO

Source text: ID:nGNX6BgshH

Further company coverage: COEP.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10